|
Market Closed -
Nasdaq
16:00:00 2026-11-12 EST
|
5-day change | 1st Jan Change | ||
| 102.91 USD | -3.66% |
|
+6.54% | +214.13% |
| 11-05 | Deutsche Bank Adjusts Spyre Therapeutics PT to $123 From $127, Maintains Buy Rating | MT |
| 11-04 | Wedbush Trims Price Target on Spyre Therapeutics to $120 From $123, Keeps Outperform Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SYRE | Delayed | |
CBOE
| SYRE | Real-time | |
|
Tradegate
| 3920 | Real-time | |
|
Deutsche Boerse AG
| 3920 | Delayed | |
|
Börse Stuttgart
| 3920 | Delayed | |
|
Boerse Muenchen
| 3920 | Real-time | |
|
Xetra
| 3920 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 109 | 109 | 106.49 |
| Spread/Res. | -5.59% | -5.59% | -3.36% |
| Spread/Supp. | +7.75% | +19.80% | +75.91% |
| Support | 95.51 | 85.9 | 58.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SYRE Stock
- Charts Spyre Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
